Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gallego‐Hernanz, Pilar
34  Ergebnisse:
Personensuche X
?
1

Combination of azacitidine, venetoclax and ruxolitinib in b..:

Systchenko, Thomas ; Chomel, Jean‐Claude ; Gallego‐Hernanz, Pilar...
British Journal of Haematology.  202 (2023)  2 - p. 284-288 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Low‐dose tyrosine kinase inhibitors before treatment discon..:

Cayssials, Emilie ; Torregrosa‐Diaz, Jose ; Gallego‐Hernanz, Pilar...
Cancer.  126 (2020)  15 - p. 3438-3447 , 2020
Link: https://doi.org/10.1002/..
 
?
3

Bacteremia due to Lachnoanaerobaculum umeaense in a patient..:

Bodin, Julie ; Gallego-Hernanz, Maria-Pilar ; Plouzeau Jayle, Chloé...
Journal of Infection and Chemotherapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Safety of empirical antibiotic therapy discontinuing for fe..:

Clément, Lemaigre ; Hélène, Deutch ; Maud, Meligne...
Journal of Infection.  88 (2024)  6 - p. 106171 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Impact of central nervous system involvement in adult patie..:

Orvain, Corentin ; Chantepie, Sylvain ; Thomas, Xavier...
Haematologica.  108 (2023)  12 - p. 3287-3297 , 2023
Link: https://doi.org/10.3324/..
 
?
6

Adjunction of a fish oil emulsion to cytarabine and daunoru..:

Gyan, Emmanuel ; Pigneux, Arnaud ; Hunault, Mathilde...
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
7

Leukemic evolution of polycythemia vera and essential throm..:

Luque Paz, Damien ; Jouanneau-Courville, Rébecca ; Riou, Jérémie...
Blood Advances.  4 (2020)  19 - p. 4887-4897 , 2020
Link: https://doi.org/10.1182/..
 
?
8

Hypomethylating agent monotherapy in core binding factor ac..:

Gabellier, Ludovic ; Peterlin, Pierre ; Thepot, Sylvain...
Annals of Hematology.  103 (2024)  3 - p. 759-769 , 2024
Link: https://doi.org/10.1007/..
 
?
9

Ulceroglandular Infection and Bacteremia Caused by Francise..:

Hennebique, Aurélie ; Caspar, Yvan ; Maurin, Max...
Emerging Infectious Diseases.  28 (2022)  2 - p. 465-467 , 2022
Link: https://doi.org/10.3201/..
 
?
10

Combination of azacitidine, venetoclax and ruxolitinib in b..:

Systchenko, Thomas ; Chomel, Jean‐claude ; Gallego-Hernanz, Pilar...
info:eu-repo/semantics/altIdentifier/doi/10.1111/bjh.18853.  , 2023
Link: https://hal.science/hal-..
 
?
11

Combination of azacitidine, venetoclax and ruxolitinib in b..:

Systchenko, Thomas ; Chomel, Jean‐claude ; Gallego-Hernanz, Pilar...
info:eu-repo/semantics/altIdentifier/doi/10.1111/bjh.18853.  , 2023
Link: https://hal.science/hal-..
 
?
12

Genetic alterations and MRD refine risk assessment for KMT2..:

Kim, Rathana ; Bergugnat, Hugo ; Pastoret, Cédric...
boreal:282178.  , 2023
Link: http://hdl.handle.net/20..
 
?
13

Genetic alterations and MRD refine risk assessment for KMT2..:

Kim, Rathana ; Bergugnat, Hugo ; Pastoret, Cédric...
boreal:282178.  , 2023
Link: http://hdl.handle.net/20..
 
?
14

Adjunction of a fish oil emulsion to cytarabine and daunoru..:

Gyan, Emmanuel ; Pigneux, Arnaud ; Hunault, Mathilde...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192636/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Leukemic evolution of polycythemia vera and essential throm..:

Paz, Damien, Luque ; Jouanneau-Courville, Rébecca ; Riou, Jeremie...
info:eu-repo/semantics/altIdentifier/doi/10.1182/bloodadvances.2020002271.  , 2020
Link: https://inserm.hal.scien..
 
1-15